Cardiometabolic
Same country, different risks: why Iranian women’s heart disease profiles expose a blind spot in prevention policy
A new IPAD study of 1,609 Iranian women found that cardiometabolic risk factors associated with premature coronary artery disease varied across ethnic groups. Hypertension, diabetes, low HDL-C, triglycerides and family history did not carry the same pattern everywhere. The message is not that ethnicity is biology. It is that prevention fails when risk tools ignore…
HEARTS 2.0: Latin America moves beyond hypertension and into cardio-kidney-metabolic care
EMA backs first oral obesity GLP-1 as pills push treatment towards mass-market adoption
As GLP-1 use expands, healthcare systems are confronting a new challenge: balancing obesity treatment with rising concerns about eating disorders and patient safety.
A new guideline is changing how health systems think about obesity, diabetes and heart disease
The next cardiometabolic battleground is ultra-processed food
ADA 2026 findings show diabetes drugs are no longer just chasing glucose
Physical activity continues to strengthen its case as a cross-disease prevention strategy
Can cortisol become the next target in type 2 diabetes?
Ozempic and Eye Health: Balancing Metabolic Benefits with Vision Risks
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.